BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31125587)

  • 1. Sexual dysfunctions are associated with major depression, chronic inflammation and anticholinergic consumption in the real-world schizophrenia FACE-SZ national cohort.
    Fond G; Godin O; Dumontaud M; Faget C; Schürhoff F; Berna F; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Leignier S; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Szoke A; Urbach M; Vidailhet P; Leboyer M; Lançon C; Boyer L; Llorca PM;
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109654. PubMed ID: 31125587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent toxoplasma infection in real-world schizophrenia: Results from the national FACE-SZ cohort.
    Fond G; Boyer L; Schürhoff F; Berna F; Godin O; Bulzacka E; Andrianarisoa M; Brunel L; Aouizerate B; Capdevielle D; Chereau I; Coulon N; D'Amato T; Dubertret C; Dubreucq J; Faget C; Lançon C; Leignier S; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Leboyer M;
    Schizophr Res; 2018 Nov; 201():373-380. PubMed ID: 29843964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort.
    Fond G; Resseguier N; Schürhoff F; Godin O; Andrianarisoa M; Brunel L; Bulzacka E; Aouizerate B; Berna F; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Gabayet F; Lançon C; Llorca PM; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Boyer L; Leboyer M;
    Eur Arch Psychiatry Clin Neurosci; 2018 Sep; 268(6):541-553. PubMed ID: 29127503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of and Risk Factors for Extrapyramidal Side Effects of Antipsychotics: Results From the National FACE-SZ Cohort.
    Misdrahi D; Tessier A; Daubigney A; Meissner WG; Schurhoff F; Boyer L; Godin O; Bulzacka E; Aouizerate B; Andrianarisoa M; Berna F; Capdevielle D; Chereau-Boudet I; D'Amato T; Dubertret C; Dubreucq J; Faget-Agius C; Lançon C; Mallet J; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Fond G;
    J Clin Psychiatry; 2019 Jan; 80(1):. PubMed ID: 30695288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The 10-year findings from the FondaMental Academic Center of Expertise for Schizophrenia (FACE-SZ): Review and recommendations for clinical practice].
    Schürhoff F; Fond G; Berna F; Bulzacka E; Godin O; Boyer L; Misdrahi D; Andrianarisoa M; Brunel L; Coulon N; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Gabayet F; Mallet J; Rey R; Lancon C; Passerieux C; Schandrin A; Urbach M; Vidailhet P; Leboyer M; Llorca PM;
    Encephale; 2019 Feb; 45(1):9-14. PubMed ID: 30327207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexual dysfunctions in schizophrenia: Beyond antipsychotics. A systematic review.
    Dumontaud M; Korchia T; Khouani J; Lancon C; Auquier P; Boyer L; Fond G
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 98():109804. PubMed ID: 31711954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohort.
    Fond G; Berna F; Andrianarisoa M; Godin O; Leboyer M; Brunel L; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Denizot H; Dubertret C; Dubreucq J; Faget C; Gabayet F; Llorca PM; Mallet J; Misdrahi D; Passerieux C; Richieri R; Rey R; Schandrin A; Urbach M; Vidailhet P; Boyer L; Schürhoff F;
    Eur Arch Psychiatry Clin Neurosci; 2017 Aug; 267(5):465-472. PubMed ID: 28238173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypovitaminosis D is associated with depression and anxiety in schizophrenia: Results from the national FACE-SZ cohort.
    Fond G; Godin O; Schürhoff F; Berna F; Bulzacka E; Andrianarisoa M; Brunel L; Aouizerate B; Capdevielle D; Chereau I; Coulon N; D'Amato T; Dubertret C; Dubreucq J; Faget C; Lançon C; Leignier S; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Leboyer M; Boyer L; Llorca PM;
    Psychiatry Res; 2018 Dec; 270():104-110. PubMed ID: 30245372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depressive symptoms and chronic peripheral inflammation are associated with impaired functional remission in schizophrenia independently of psychotic remission.
    Fond G; Faugere M; Richieri R; Cermolacce M; Korchia T; Micoulaud-Franchi JA; Sunhary de Verville PL; Boyer L; Lançon C
    J Affect Disord; 2021 Feb; 280(Pt A):267-271. PubMed ID: 33220563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remission of depression in patients with schizophrenia and comorbid major depressive disorder: results from the FACE-SZ cohort.
    Fond G; Boyer L; Berna F; Godin O; Bulzacka E; Andrianarisoa M; Brunel L; Aouizerate B; Capdevielle D; Chereau I; Coulon N; D'Amato T; Dubertret C; Dubreucq J; Faget C; Leignier S; Lançon C; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Leboyer M; Schürhoff F; Llorca PM;
    Br J Psychiatry; 2018 Aug; 213(2):464-470. PubMed ID: 29871707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory DEpression Advances in Schizophrenia (IDEAS): A precision medicine approach of the national FACE-SZ cohort.
    Fond G; Godin O; Schürhoff F; Berna F; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Leignier S; Lançon C; Mallet J; Marulaz L; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Leboyer M; ; Boyer L; Llorca PM
    J Affect Disord; 2019 Feb; 245():468-474. PubMed ID: 30428447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohort.
    Fond G; Godin O; Schürhoff F; Berna F; André M; Aouizerate B; Capdevielle D; Chereau I; D' Amato T; Dubertret C; Dubreucq J; Faget C; Lançon C; Leignier S; Mallet J; Misdrahi D; Passerieux C; Pignon B; Rey R; Szoke A; Urbach M; Vidailhet P; Leboyer M; Boyer L; Llorca PM;
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jul; 101():109927. PubMed ID: 32173456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort.
    Fond G; Godin O; Boyer L; Berna F; Andrianarisoa M; Coulon N; Brunel L; Bulzacka E; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Leignier S; Lançon C; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Schürhoff F; Leboyer M;
    Eur Arch Psychiatry Clin Neurosci; 2019 Dec; 269(8):985-992. PubMed ID: 29808267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set.
    Fond G; Godin O; Brunel L; Aouizerate B; Berna F; Bulzacka E; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Strat Y; Micoulaud-Franchi JA; Misdrahi D; Rey R; Richieri R; Passerieux C; Schandrin A; Schürhoff F; Tronche AM; Urbach M; Vidalhet P; Llorca PM; Leboyer M;
    J Affect Disord; 2016 Feb; 191():209-15. PubMed ID: 26674214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-reported pain in patients with schizophrenia. Results from the national first-step FACE-SZ cohort.
    Fond G; Boyer L; Andrianarisoa M; Godin O; Bulzacka E; Berna F; Brunel L; Coulon N; Aouizerate B; Capdevielle D; Chereau I; D'amato T; Denizot H; Dubertret C; Dubreucq J; Faget C; Leignier S; Mallet J; Misdrahi D; Rey R; Lancon C; Passerieux C; Schandrin A; Urbach M; Vidailhet P; Leboyer M; Schurhoff F; Llorca PM;
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jul; 85():62-68. PubMed ID: 29678770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations of the schizophrenia expert center network for the screening prevention and treatment of sleep disorders based on the results from the real-world schizophrenia FACE-SZ national cohort.
    Sunhary de Verville PL; Etchecopar-Etchart D; Richieri R; Godin O; Schürhoff F; Berna F; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Leignier S; Mallet J; Misdrahi D; Passerieux C; Pignon B; Rey R; Urbach M; Vidailhet P; Leboyer M; Llorca PM; Lançon C; Boyer L; Fond G;
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110275. PubMed ID: 33582207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cigarette smoking and schizophrenia: a specific clinical and therapeutic profile? Results from the FACE-Schizophrenia cohort.
    Mallet J; Le Strat Y; Schürhoff F; Mazer N; Portalier C; Andrianarisoa M; Aouizerate B; Berna F; Brunel L; Capdevielle D; Chereau I; D'Amato T; Denizot H; Dubreucq J; Faget C; Gabayet F; Lançon C; Llorca PM; Misdrahi D; Rey R; Roux P; Schandrin A; Urbach M; Vidailhet P; Fond G; Dubertret C;
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):332-339. PubMed ID: 28663115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset.
    Fond G; Boyer L; Favez M; Brunel L; Aouizerate B; Berna F; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq ; Faget C; Gabayet F; Laouamri H; Lancon C; Le Strat Y; Misdrahi D; Rey R; Passerieux C; Schandrin A; Schurhoff F; Tronche AM; Urbach M; Vidalhet P; Llorca PM; Pelissolo A;
    Psychopharmacology (Berl); 2016 Feb; 233(4):571-8. PubMed ID: 26630993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal C-reactive protein blood levels as a specific biomarker of major depression and non-remission under antidepressants in schizophrenia.
    Fond G; Micoulaud-Franchi JA; Faugere M; Boyer L; Faget-Agius C; Lançon C; Richieri R; Cermolacce M
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109800. PubMed ID: 31676465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-Morbidity between Major Depression and Schizophrenia: Prevalence and Clinical Characteristics.
    Bener A; Dafeeah EE; Abou-Saleh MT; Bhugra D; Ventriglio A
    Psychiatr Danub; 2020; 32(1):78-83. PubMed ID: 32303036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.